Will INO stock go up?
The 4 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 8.00 and a low estimate of 1.00. The median estimate represents a +43.68% increase from the last price of 1.74.
Is INO stock a good investment?
The Inovio Pharmaceuticals stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock.
Is INO a buy Zacks?
The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X Industry....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy25.08%2Buy18.56%3Hold10.15%4Sell5.79%2 more rows
What is the long range forecast for INO stock?
Inovio Pharmaceuticals Inc quote is equal to 1.765 USD at 2022-06-04. Based on our forecasts, a long-term increase is expected, the "INO" stock price prognosis for 2027-05-26 is 5.026 USD. With a 5-year investment, the revenue is expected to be around +184.73%. Your current $100 investment may be up to $284.73 in 2027.
Whats going on with Inovio?
Inovio Pharmaceuticals encountered a series of headwinds in its quest to market its experimental coronavirus vaccine, INO-4800. Recently, the company discontinued a phase 3 clinical study for this candidate.
Does inovio have a Covid vaccine?
In contrast, the heterologous booster market offers greater opportunities due to the endemic phase of COVID-19. So, instead of assessing INO-4800 as a two-dose vaccine, Inovio and its developmental partner Advaccine will examine the drug candidate as a heterologous booster to an inactivated COVID-19 vaccine.
What is the target price for Ino?
Stock Price Target INOHigh$8.00Median$2.50Low$1.00Average$3.50Current Price$1.71